• Cushman and Copeland Named to List of World’s Most Influential Researchers
    November 20, 2019
    Two University of Vermont Larner College of Medicine faculty have been named to a list of the world’s most influential researchers, based on the number of times their published studies have been cited by other researchers over the past decade. Researchers on the list are in the top 1 percent of all scholars whose work has been cited. The prestigious Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.
  • UVM Health Network Pilot Project Offers Patients Genomic DNA Testing
    November 18, 2019
    The UVM Health Network is partnering with Invitae and LunaPBC on a pilot project to offer Genomic DNA Testing to patients as part of their clinical care. The pilot program is the beginning of an effort to increase the integration of genetic disease risks into routine medical care, which holds promise for providing Vermonters with valuable information to guide their health decisions.
  • Research Excellence and Scholarship Highlighted at Annual Celebration Events
    October 30, 2019
    The Larner College of Medicine's fourth annual "Celebrating Excellence in Research" series featured two days of presentations and recognition designed to highlight research performed by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
  • Dixon Named Director of Vermont Lung Center
    October 22, 2019
    Anne Dixon, M.A., BM BCh, professor of medicine and division chief of pulmonary disease & critical care medicine at the Larner College of Medicine at the University of Vermont, has been named the new director of the Vermont Lung Center.
  • Irvin & Colleagues Flavored E-Cigs & Asthma Study Covered by National Media Outlets
    October 16, 2019
    (OCTOBER 15, 2019) Several news outlets recently covered a research study on flavored e-cigarettes and asthma published in Nature Scientific Reports by Larner faculty and trainees, including senior author and Professor of Medicine Charles Irvin, Ph.D. The study was funded through UVM's Tobacco Center on Regulatory Science (TCORS) grant.